Sun Evaluating Plant-Based Candidates To Treat Zika
Executive Summary
Sun Pharma expects to study plant-based drug candidates to treat the Zika virus in a tie-up with India’s state-run National Institute of Virology, as part of a wider initiative to test new medicines to act against mosquito-borne diseases.
You may also be interested in...
Sun Dips Toe Into Vaccines With Dengvaxia Challenge
India's top-ranked drug firm Sun Pharma is vying for a play in the dengue vaccines space via a collaboration with the non-profit research organization, International Centre for Genetic Engineering and Biotechnology. The partners expect their vaccine candidate to potentially best live-attenuated dengue vaccine candidates, including Sanofi's Dengvaxia.
Sun Partners Indian Research Agency For ‘Malaria-Free’ Initiative
India's biggest drug firm, Sun Pharma, has teamed up with the Indian Council of Medical Research in a public-private partnership to create a malaria-free India. But the initiative comes as scientists worry that a powerful new drug-resistant strain of the disease could be about to emerge in the country.
Top US Court Lifts Discovery Stay On Price-Fixing
The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.